EGR3 and B-cell chronic lymphocytic leukemia: Due to the relevance of HELQ and EGR3 with disease course and prognosis of CLL, we performed GSEA to reveal the significantly activated and/or suppressed signaling pathways correlating with HELQ/EGR3 overexpression (Fig. 11 and Table 3).